Anzeige
Mehr »
Login
Mittwoch, 26.08.2020 Börsentäglich über 12.000 News von 650 internationalen Medien
Alle ausgestochen und neuen SILBER-DISTRIKT erworben! Nächste Raketen-Stufe zündet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P2NP ISIN: US83548R1059 Ticker-Symbol: H3D 
Tradegate
25.08.20
20:58 Uhr
2,680 Euro
-0,620
-18,79 %
Branche
Nahrungsmittel/Agrar
Aktienmarkt
Sonstige
1-Jahres-Chart
5-Tage-Chart
Realtime Geld Brief Zeit
2,520 2,780 25.08.

Aktuelle News zur SONNET BIOTHERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
Zeit Aktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
Di Sonnet Bio secures $10.5M from exercise of series A warrants 4
Di Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Receives $10.5 Million from Exercise of Series A Warrants 166 PRINCETON, NJ / ACCESSWIRE / August 25, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs...
► Artikel lesen
Mo Mid-Day Market Update: Dow Rises 1%; Sonnet BioTherapeutics Shares Spike Higher 11
SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
Mo Stock Alert: Sonnet BioTherapeutics Surges 41% 12
Mo Sonnet Bio up 96% riding wave of buying on FDA nod for convalescent plasma 15
14.08. Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quaterly Report 4
14.08. Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report 2
14.08. Sonnet BioTherapeutics reports Q3 results 6
14.08. Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year Third Quarter Business and Earnings Update 289 Company successfully completes warrant repricing and exchange, with gross proceeds to total $10.5 million Company Enters Negotiation for Potential Licensing of Neuropathies Asset PRINCETON, NJ /...
► Artikel lesen
04.08. Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report 8
04.08. Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million 296 PRINCETON, NJ / ACCESSWIRE / August 4, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs...
► Artikel lesen
04.08. Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Signs Letter of Intent for Potential Licensing of Neuropathies Asset to New Life Therapeutics 341 Potential Collaboration in Diabetic Peripheral Neuropathy and Chemotherapy-Induced Peripheral Neuropathy for ASEAN Region $500,000 Non-Refundable Payment to Sonnet on Signing of Letter of Intent Potential...
► Artikel lesen
31.07. Sonnet BioTherapeutics leads healthcare gainers; ThermoGenesis and Edesa Biotech among losers 25
20.07. Sonnet BioTherapeutics, Inc.: Sonnet Biotherapeutics Announces Positive Preclinical Results from an Initial Efficacy Study Exploring the Combination of Granulocyte-Macrophage Colony-Stimulating Factor with Interleukins 18 and 12 260 Data provide proof-of-concept for advancing SON-2014, a bispecific combination of GMcSF and IL-18 The company will further explore the utility of a bispecific combination of GMcSF and IL-12 PRINCETON...
► Artikel lesen
15.07. Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present at the 2020 BTIG Virtual Biotechnology Conference 271 PRINCETON, NJ / ACCESSWIRE / July 15, 2020 / Sonnet BioTherapeutics, Inc., a company developing innovative targeted biologic drugs with enhanced single or bispecific mechanisms, announced today that...
► Artikel lesen
09.07. Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report 5
20.05. Sonnet BioTherapeutics Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans 16
18.05. Sonnet BioTherapeutics reports Q1 results 15
18.05. Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Holdings Provides Business and Earnings Update 337 Company successfully completes merger with private Sonnet BioTherapeutics Company Launches Initiative to Explore FHAB Technology in Antiviral Applications PRINCETON, NJ / ACCESSWIRE / May 18, 2020...
► Artikel lesen
18.05. Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report 3
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1